DIVA Laboratories

DIVA Laboratories EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DIVA Laboratories (4153.TWO) as of Oct 17, 2026 is 109.36 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 103.02 M TWD — a change of 6.15% (higher).

EBITDA

109.36 MTWD

YoY

6.15%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DIVA Laboratories is 2025 109.36 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DIVA Laboratories was 2024 103.02 M TWD. It decreases by 6.15% higher compared to the previous year.

The DIVA Laboratories EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
51.98 M TWD
Jan 1, 2019
69.22 M TWD
Jan 1, 2020
63.04 M TWD
Jan 1, 2021
27.64 M TWD
Jan 1, 2022
124.77 M TWD
Jan 1, 2023
97.17 M TWD
Jan 1, 2024
103.02 M TWD
Jan 1, 2025
109.36 M TWD
The DIVA Laboratories EBITDA history
YEAREBITDAYoY
109.36 MTWD+6.15%
103.02 MTWD+6.03%
97.17 MTWD-22.12%
124.77 MTWD+351.35%
27.64 MTWD-56.15%
63.04 MTWD-8.92%
69.22 MTWD+33.15%
51.98 MTWD-237.09%
-37.92 MTWD-145.40%
83.52 MTWD-46.12%
155.02 MTWD+26.55%
122.50 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

DIVA Laboratories Stock analysis

What does DIVA Laboratories do? DIVA Laboratories Ltd., headquartered in Taipei, Taiwan, operates in the Information Technology sector, specializing in Electrical Equipment. The company designs and manufactures precision displays for medical imaging systems, including PACS, endoscopic devices, and ultrasound equipment, as well as TFT LCD products for touch screen systems and Panel PCs. Listed on 11 October 2010, DIVA employs 133 people and serves global markets with its display solutions. DIVA Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DIVA Laboratories stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DIVA Laboratories is 109.36 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DIVA Laboratories changed from 103.02 M TWD to 109.36 M TWD, representing a 6.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) DIVA Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s DIVA Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — DIVA Laboratories

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — DIVA Laboratories